Penumbra (PEN) Free Cash Flow (2014 - 2026)
Penumbra's (PEN) quarterly Free Cash Flow came in at $75.2 million in Q1 2026, up 59.16% year-on-year from $47.2 million in Q1 2025, and down 9.12% on a QoQ basis from $82.7 million in Q4 2025.
Penumbra (PEN) Free Cash Flow (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Free Cash Flow data on file, last reported at $75.2 million in Q1 2026.
- On a quarterly basis, Free Cash Flow rose 59.16% year-over-year to $75.2 million in Q1 2026; TTM through Mar 2026 was $261.3 million, a 61.24% increase from a year earlier, with the FY2025 full-year figure at $233.4 million, up 58.43% from the prior year.
- Free Cash Flow for Q1 2026 stood at $75.2 million, down from $82.7 million in the prior quarter.
- Over the last five years, Free Cash Flow for PEN reached as high as $85.8 million in Q3 2025 and fell as low as -$44.0 million in Q2 2022.
- Historically, Free Cash Flow has averaged $29.1 million across 5 years, with a median of $31.0 million in 2023.
- Across the five-year window, Free Cash Flow slumped 2729.97% in 2022 and jumped 261.17% in 2023, its largest moves.
- Year by year, Free Cash Flow stood at $14.8 million in 2022, then jumped by 145.97% to $36.4 million in 2023, then grew by 25.81% to $45.7 million in 2024, then jumped by 80.9% to $82.7 million in 2025, then decreased by 9.12% to $75.2 million in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were $75.2 million in Q1 2026, $82.7 million in Q4 2025, and $85.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | 75.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.19 Mn |
| Mar 31, 2026 | 75.19 Mn |
| Dec 31, 2025 | 82.74 Mn |
| Dec 31, 2025 | 82.74 Mn |
| Sep 30, 2025 | 85.76 Mn |
| Sep 30, 2025 | 85.76 Mn |
| Jun 30, 2025 | 17.63 Mn |
| Jun 30, 2025 | 17.63 Mn |
| Mar 31, 2025 | 47.24 Mn |
| Mar 31, 2025 | 47.24 Mn |
| Dec 31, 2024 | 45.74 Mn |
| Dec 31, 2024 | 45.74 Mn |
| Sep 30, 2024 | 51.02 Mn |
| Sep 30, 2024 | 51.02 Mn |
| Jun 30, 2024 | 18.08 Mn |
| Jun 30, 2024 | 18.08 Mn |
| Mar 31, 2024 | 32.47 Mn |
| Mar 31, 2024 | 32.47 Mn |
| Dec 31, 2023 | 36.35 Mn |
| Dec 31, 2023 | 36.35 Mn |